Markets & Investing

Temasek's portfolio grew to record-high $308b in 2018

One-year returns jumped to 12%, whilst ten-year returns grew 5%.

Temasek's portfolio grew to record-high $308b in 2018

One-year returns jumped to 12%, whilst ten-year returns grew 5%.

SEA investment deals ballooned to US$21.9b

Majority of investments were pumped into real estate, energy, and technology.

Singapore's PE and VC deals reached US$19.8b in Q1 2018

It pushed SEA investment deals to skyrocket to US$21.9b from US$687m in Q1 2017.

CityDev's share price hit by surprise property policy

It has the largest inventory of about 2,000 units for launching from H2 2018 to 2019.

Sembcorp Industries to get $200m of 5% perpetual securities

It will cease trading in SGX securities after redemption.

SGX to amend financial and capital requirements for bank and remote members

One of the changes aims to rely on the requirements by the home regulator instead of SGX.

Xiaomi call warrants to start SGX trading on 9 July

Its Hong Kong IPO will start on the same date.

Singapore's Makara Innovation Fund secures US$150m from Jordanian investor

Makara Capital will utilise it to fund late-stage start-ups and growth-stage companies.

APAC IPO proceeds ballooned 80% to US$3.1b

Vietnam led the growth with a real estate developer listing of US$3.1b.

Singapore IPO proceeds plummeted 20% to US$408m

Small-cap listings dominated the market amidst uncertainty and trade tensions.

Singapore firms' payment performance weakened in Q2

Prompt payments fell slightly by 1.65 ppt to 49.55% of total transactions.

Daily Briefing: Fuel shortage in Asia pushed Singapore oil prices to a 3-year high; Starhub welcomes new CEO

And Golden Gate Ventures joined a $19.9m funding for a Singapore care-giving startup.

9 in 10 planned M&A deals failed in the past year

Nearly 3 in 5 bosses blamed competition and disagreement over the valuation price.

PropNex Realty debuts on SGX Mainboard at 68.5 cents per share

Its $240m market cap boosted the real estate cluster's cap to $179b.

EDBI joins US$220m funding for China bio-pharma player

I-Mab will use the fund to further develop its pre-clinical and clinical assets.

PropNex Realty raises $38m from IPO

Its publicly offered shares were 24.6 times oversubscribed.